VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $146,000 | -39.4% | 10,223 | +942.1% | 0.01% | -45.5% |
| Q2 2015 | $241,000 | +20.5% | 981 | +7.6% | 0.02% | +22.2% |
| Q1 2015 | $200,000 | -99.9% | 912 | -45.6% | 0.02% | +5.9% |
| Q4 2014 | $243,076,000 | +97130.4% | 1,675 | -13.2% | 0.02% | -10.5% |
| Q3 2014 | $250,000 | +2.9% | 1,929 | 0.0% | 0.02% | 0.0% |
| Q2 2014 | $243,000 | -21.4% | 1,929 | -16.5% | 0.02% | -29.6% |
| Q1 2014 | $309,000 | -29.3% | 2,309 | -43.0% | 0.03% | -35.7% |
| Q3 2013 | $437,000 | – | 4,051 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |